Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 226–250 of 27,380 studies, newest first · page 10 of 1096.

October 2026 25

  1. 2026-10-09

    The transition to retirement and dementia risk: An application of sequence analysis

    ⚠ Preprint — not yet peer-reviewed Long-term cohort studies medRxiv

    Key finding: Retirement timing alone showed limited association with later-life dementia risk, whereas sustained part-time employment and disability-related trajectories were more strongly associated with dementia risk. +4 more findings

    Scored 37 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  2. 2026-10-09

    Spermine inhibits ferroptosis in vascular dementia rats by intervening Nrf2/SLC7A11/GPX4 expression in chondriosome

    ⚠ Preprint — not yet peer-reviewed Vascular contributions Research Square

    Key finding: Spermine exerts neuroprotective effects in VaD by inhibiting TRPM2-mediated oxidative stress and activating the Nrf2/SLC7A11/GPX4 pathway, thereby suppressing ferroptosis. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  3. 2026-10-09

    Carbonic anhydrase inhibition rescues heart function in the Tg2576 Alzheimer’s mouse model by ameliorating cardiac amyloid-β pathology and neurotrophic-signaling impairment

    ⚠ Preprint — not yet peer-reviewed Vascular contributions bioRxiv

    Key finding: We have recently shown that Aβ aggregates disrupt neuro-signaling and deplete neurotrophic factors (particularly BDNF) in the heart of AD mouse models and human subjects. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  4. 2026-10-09

    Navigating Life After Dementia Diagnosis: Questions, Challenges, and Support Needs Among Dementia Dyads

    ⚠ Preprint — not yet peer-reviewed Risk factors medRxiv

    Key finding: Dementia dyads experience substantial informational, emotional, and practical support needs in the early stages of MCI and AD/ADRD. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  5. 2026-10-09

    Seasonally Normalized Vitamin D Status and Long-Term Mortality and Multisystem Disease Risk in the UK Biobank

    ⚠ Preprint — not yet peer-reviewed Risk factors medRxiv

    Key finding: Seasonally normalized 25(OH)D identifies a reproducible state of systemic vulnerability while reducing exposure misclassification caused by calendar timing of measurement. +4 more findings

    Scored 50 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  6. 2026-10-09

    MTHFR*677C>T produces distinct prodromal disease signatures in a mouse model of late-onset Alzheimer’s disease

    ⚠ Preprint — not yet peer-reviewed TREM2 and immune genetics Research Square

    Key finding: These data further support the use of the LOAD2.Mthfr 677C>T mouse model to study aspects of ADRD such as cerebrovascular compromise. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  7. 2026-10-09

    Locus coeruleus intensity as a marker of early-stage Alzheimer’s disease: associations with plasma pTau 217 and memory

    ⚠ Preprint — not yet peer-reviewed Genetics medRxiv

    Key finding: These findings support MRI-derived LC intensity as a marker of early AD-related processes and suggest that LC intensity may provide complementary information not captured by plasma pTau 217 alone. +3 more findings

    Scored 44 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  8. 2026-10-08

    Cross-Tissue Inflammatory Convergence Supports a Putative Muscle–Brain Axis in Alzheimer’s Disease

    ⚠ Preprint — not yet peer-reviewed Mild cognitive impairment bioRxiv

    Key finding: Aging muscle showed increased inflammatory, extracellular-matrix, and stromal communication programs. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  9. 2026-10-08

    Disease stage-sensitive MFSD2A-caveolae axis insigates hippocampal blood–brain barrier disruption in Alzheimer’s disease

    ⚠ Preprint — not yet peer-reviewed Vascular contributions bioRxiv

    Key finding: Analysis of human single-nucleus transcriptomic data further demonstrated that vascular expression of MFSD2A declined during transition from mild cognitive impairment to established AD. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  10. 2026-10-08

    The Gut–Liver–Brain Axis in Neurodegeneration: Unraveling Metabolic–Immune Crosstalk from Peripheral Sensing to Central Vulnerability

    ⚠ Preprint — not yet peer-reviewed Prevention and risk Preprints.org

    Key finding: However, increasing evidence indicates that systemic metabolic dysfunction, chronic inflammation, intestinal dysbiosis, hepatic abnormalities, and barrier impairment may substantially influence disease susceptibility and progression.

    Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  11. 2026-10-08

    Vibrotactile transcutaneous auricular vagus nerve stimulation (taVNS) during working memory: convergent electrophysiological evidence for cortical efficiency

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging bioRxiv

    Key finding: Our results converge on the conclusion that vtaVNS does not uniformly amplify cortical responses to external stimuli. +4 more findings

    Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  12. 2026-10-08

    The Somnogenesis System: A Proposed Biological System for Psychiatry

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging Preprints.org

    Key finding: Each hub carries an established, distinct function, and the evidence suggests these functions operate as a dependency chain rather than as independent, parallel contributions, consistent with the proposed existence of a genuine biological system rather than three regions coincidentally active at the same time. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  13. 2026-10-08

    Plasma metabolomic profiling of frailty in older adults at risk of dementia

    ⚠ Preprint — not yet peer-reviewed Biomarkers medRxiv

    Key finding: Frailty index was associated with carboxylic acids and derivatives, fatty acyls and organooxygen compounds across multiple clusters, and a large number of lipids were linked to frailty score, potentially implicating dysregulation of energy metabolism in the pathophysiology of frailty and forming a panel of predictive biomarkers of at risk patients. +2 more findings

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  14. 2026-10-08

    Neuroprotective Role of Vitamin D Against LPS-Induced Cognitive Deficits in Rats: Targeting Hippocampal PERK-ATF4-CHOP-Mediated ER Stress and Calcium Dyshomeostasis

    ⚠ Preprint — not yet peer-reviewed Biomarkers Research Square

    Key finding: In conclusion, VitD exerted a multifaceted protective effect against LPS-induced cognitive dysfunction, suggesting VitD as a promising approach for mitigating AD-related cognitive decline, potentially involving attenuation of hippocampal neuroinflammation and ER stress, with modulation of the PERK-ATF4-CHOP pathway, and alleviation of Ca²⁺ dysregulation.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  15. 2026-10-07

    Forecasting Alzheimer’s disease progression using non-imaging clinical features and XGBoost

    ⚠ Preprint — not yet peer-reviewed Digital health tools medRxiv

    Key finding: Machine learning (ML) methods have shown promise in modeling clinical trajectories associated with neurodegenerative disorders such as Alzheimer’s disease (AD). +2 more findings

    Scored 50 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  16. 2026-10-07

    A Machine Learning-Based Framework for differential screening of Neurodegenerative Dementias using routine clinical data

    ⚠ Preprint — not yet peer-reviewed Getting a diagnosis Research Square

    Key finding: Symptom chronology emerged as a robust diagnostic discriminator, underscoring the clinical value of temporal disease trajectories. +2 more findings

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  17. 2026-10-07

    Perceived Barriers for Advance Care Planning Among People with Dementia and Family Caregivers: A Systematic Review of Qualitative Studies

    ⚠ Preprint — not yet peer-reviewed End-of-life care Preprints.org

    Key finding: Two analytical themes were identified: (1) challenges in preserving the person's voice throughout the dementia trajectory, reflecting a shift toward caregiver-mediated decision-making, assumptions about capacity, and delayed ACP initiation; and (2) challenges in maintaining continuity of expressed values and preferences over time, reflecting uncertainty about future care needs and the limitations of one-time ACP conversations. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  18. 2026-10-07

    TLR7-mediated autoimmunity targets Robo3 to drive astrogliosis in frontotemporal dementia

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms Research Square

    Key finding: Together, these results offer critical insights into how TLR7-mediated autoimmune dysfunction targets Robo3 to drive neuroinflammation and neurodegeneration in FTD.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  19. 2026-10-07

    Human multiscale transcriptomics identifies the NLRP3 inflammasome as a convergent druggable target in Alzheimer’s disease: validation with dimethyl itaconate in 5xFAD mice

    ⚠ Preprint — not yet peer-reviewed Brain tissue and pathology Research Square

    Key finding: Meta-analysis revealed significant upregulation of inflammasome-related genes, including GSDMD (log₂FC = 0.72; pooled p = 5.4 × 10 -5 ), PYCARD , and CASP1 ; GSDMD expression was highest at Braak stage VI, consistent with progressive engagement of the pyroptotic effector arm in advanced AD. +3 more findings

    Scored 47 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  20. 2026-10-07

    Brain region- and solubility-dependent proteomic signatures of neurofibrillary tangle pathology in Alzheimer’s disease

    ⚠ Preprint — not yet peer-reviewed Brain tissue and pathology medRxiv

    Key finding: A total of 5,573 protein groups were identified, including 452 differentially expressed proteins (DEPs), 183 bidirectional expression proteins (BEPs), and 693 differentially soluble proteins (DSPs) associated with NFT pathology. +1 more finding

    Scored 31 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  21. 2026-10-07

    Generalizing Amyloid β Pathology from Postmortem Human Brains with Vision Foundation Models for Lesion Quantification

    ⚠ Preprint — not yet peer-reviewed Vascular contributions medRxiv

    Key finding: The ViTamyloid classifier achieved strong feature-separation metrics, yielding area under the receiver operating characteristic curve (AUROC) and precision-recall curve (AUPRC) values of 0.994/0.958 for CCP, 0.989/0.945 for CGP, 0.992/0.977 for CAA Type 1, and 0.997/0.978 for CAA Type 2. +3 more findings

    Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  22. 2026-10-07

    Triple-Omics Analysis Unveiled the Neuroprotective Mechanisms of Akkermansia muciniphila in an Environmental Exposure-Linked Mouse Model of Alzheimer’s Disease

    ⚠ Preprint — not yet peer-reviewed Risk factors bioRxiv

    Key finding: These findings identify restoration of hippocampal transcript fate and splice-isoform selection as a mechanism potentially underlying A. muciniphila -mediated protection against Cd neurotoxicity, and establish post-transcriptional RNA regulation as a gut-brain target for mitigating environmentally driven neurotoxicity. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  23. 2026-10-07

    PFKFB3 inhibition restores β-cell responsiveness to acetylcholine in a 3xTg-AD pancreatic tissue-slice model

    ⚠ Preprint — not yet peer-reviewed Risk factors bioRxiv

    Key finding: Compared to wild-type controls, β-cells showed weaker glucose-stimulated and acetylcholine-potentiated Ca 2+ activity, accompanied by increased nuclear PFKFB3 positivity in insulin-defined islet-cell populations, used here as a PFKFB3-associated stress-state marker.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  24. 2026-10-07

    A Multiethnic Analysis of DNA Methylation Reveals Links Between Alzheimer’s Disease and Metabolic Comorbidities

    ⚠ Preprint — not yet peer-reviewed Risk factors medRxiv

    Key finding: The two sites associated with interactions between AD and a metabolic condition could explain the influence that those conditions have on the risk for AD and are prime candidates for future study. +2 more findings

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  25. 2026-10-07

    Analytical performance of a delayed-centrifugation blood collection tube for remote blood biomarker assessment

    ⚠ Preprint — not yet peer-reviewed Biomarkers medRxiv

    Key finding: The NULISA assay demonstrated excellent technical reproducibility (intra- and inter-plate coefficients of variation [CVs] <10%). +3 more findings

    Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

Browse the library by subject, with the full score breakdown →